(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(Pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-Dodecahydro-1H-Cyclopenta[a]Phenanthren-3-ol (3S,8R,9S,10R,13S,14S)-10,13-二甲基-17-(吡啶-3-基)-2,3,4,7,8,9,10,11,12,13,14,15-十二烷基-1H-环戊[a]菲蒽-3-醇

CAS 154229-19-3 MFCD00924100

化学结构图

154229-19-3
SMILES: C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2C1C=NC=CC=1

化学属性

Mol. FormulaC24H31NO
Mol. Weight350
Melting Point226.0 to 230.0 deg-C

别名和识别编码

Chemical Name(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(Pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-Dodecahydro-1H-Cyclopenta[a]Phenanthren-3-ol
CAS Number154229-19-3
Synonym (3?)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol CB 7598
Chemical Name Translation(3S,8R,9S,10R,13S,14S)-10,13-二甲基-17-(吡啶-3-基)-2,3,4,7,8,9,10,11,12,13,14,15-十二烷基-1H-环戊[a]菲蒽-3-醇
MDL NumberMFCD00924100
Reaxys-RN7309269
PubChem Substance ID253661112
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

分类

  • Pharmaceuticals
  • Intermediates & Fine Chemicals
  • Steroids,

产品应用

  • Abiraterone, a steroidal cytochrome P 450 17?-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent pr

相关文献及参考

  • [2]. Richards J, et al. Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100. Cancer Res. 2012 May 1;72(9):2176-82.
  • [3]. Stein MN, et al. Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer. Asian J Androl. 2014 May-Jun;16(3):387-400.
  • [4]. Li R, et al. Abiraterone inhibits 3β-hydroxysteroid dehydrogenase: a rationale for increasing drug exposure in castration-resistant prostate cancer. Clin Cancer Res. 2012 Jul 1;18(13):3571-9.
  • [5]. Kumar SV, et al. Validated RP-HPLC/UV method for the quantitation of abiraterone in rat plasma and its application to a pharmacokinetic study in rats. Biomed Chromatogr. 2013 Feb;27(2):203-7.
  • [6]. Stein MN, et al. Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer. Asian J Androl. 2014 May-Jun;16(3):387-400.
  • Den

安全信息

Hazard statements
  • H361 Suspected of damaging fertility or the unborn child 怀疑对生育能力或未出生婴儿造成伤害
GHS Symbol
Signal word
Precautionary statements
  • P260 Do not breathe dust/fume/gas/mist/vapours/spray. 不要吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
  • P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
  • P201 Obtain special instructions before use. 使用前获取专门指示。
  • P501 Dispose of contents/container to..… 处理内容物/容器.....
  • P405 Store locked up. 上锁保管。
  • P202 Do not handle until all safety precautions have been read and understood. 已阅读并理解所有的安全预防措施之前，切勿操作。
  • P308+P313
Storage condition 0-10°C

系列性分类

  1. Medical Research Areas
  2. Metabolism
  3. Cytochrome P450  (细胞色素P450)

相关产品推荐